We are live on ! Find out more
GPP

Great Point Partners Portfolio holdings

AUM $435M
1-Year Est. Return 318.81%
This Fund
S&P 500
This Quarter Est. Return
+49.72%
1 Year Est. Return
+318.81%
3 Year Est. Return
+553.97%
5 Year Est. Return
+856.21%
10 Year Est. Return
+18,148.08%
AUM
$144M
AUM Growth
–
Cap. Flow
+$122M
Cap. Flow %
84.64%
Top 10 Hldgs %
70.1%
Holding
32
New
31
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
+$20.6M
2
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
+$14.5M
3
AMBI
Ambit Biosciences Corp
AMBI
+$11.7M
4
FLNA
Filana Therapeutics
FLNA
+$7.27M
5
NSPH
NANOSPHERE INC. COM NEW
NSPH
+$6.24M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 42.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HPTX
1
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$21.4M 14.88%
+820,906
New +$20.6M
FURX
2
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$15.4M 10.66%
+349,356
New +$14.5M
AMBI
3
DELISTED
Ambit Biosciences Corp
AMBI
$13.7M 9.5%
+883,459
New +$11.7M
NUWE icon
4
Nuwellis
NUWE
$160K
– –
0
– –
GERN icon
5
Geron
GERN
$828M
$8.31M 5.77%
+2,626,152
New +$4.3M
FLNA
6
Filana Therapeutics
FLNA
$48.8M
$7.92M 5.49%
+415,836
New +$7.27M
GENT
7
DELISTED
GENTIUM SPA ADS
GENT
$6.1M 4.23%
+224,767
New +$3.65M
SPHS
8
DELISTED
Sophiris Bio, Inc.
SPHS
$5.99M 4.16%
+1,280,000
New +$5.9M
NSPH
9
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$5M 3.47%
+125,000
New +$6.24M
DRTX
10
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$4.6M 3.19%
+508,472
New +$4.22M
HTWR
11
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$4.39M 3.05%
+60,000
New +$5.12M
ALBO
12
DELISTED
Albireo Pharma Inc
ALBO
$4.2M 2.92%
+44,483
New +$5.79M
TRIB
13
Trinity Biotech
TRIB
$7.83M
$4.11M 2.85%
+1,260
New +$3.68M
STRM
14
DELISTED
Streamline Health Solutions
STRM
$3.62M 2.51%
+31,725
New +$3.47M
VOLC
15
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$3.41M 2.37%
+142,500
New +$3.03M
AMRN
16
CALL
Amarin Corp
AMRN
$299M
$3.16M 2.19%
+25,000
New +$2.99M
NDZ
17
DELISTED
NORDION INC COM STK (CDA)
NDZ
$2.59M 1.8%
+299,902
New +$2.34M
ACHV icon
18
Achieve Life Sciences
ACHV
$659M
$2.45M 1.7%
+120
New +$2.49M
SVRA icon
19
Savara
SVRA
$1.12B
$2.39M 1.66%
+77,749
New +$2.41M
GIVN
20
DELISTED
GIVEN IMAGING LTD
GIVN
$2.27M 1.57%
+118,000
New +$1.98M
SRGA
21
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$2.27M 1.57%
+20,201
New +$2.29M
PLX icon
22
Protalix BioTherapeutics
PLX
$191M
$1.81M 1.25%
+39,901
New +$2.05M
LITS
23
Lite Strategy Inc
LITS
$32.8M
$1.77M 1.23%
+7,883
New +$1.23M
TXMD icon
24
TherapeuticsMD
TXMD
$23.5M
$1.22M 0.85%
+8,333
New +$1.01M
ARQL
25
DELISTED
Arqule Inc
ARQL
$871K 0.6%
+373,926
New +$939K
1
2

Similar funds

GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
SWG
Summit Wealth Group White River Junction, Vermont $436M AUM 13.96% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $436M AUM 42.05% 1-Year Est. Return
VIM
VELA Investment Management New Albany, Ohio $436M AUM 15.16% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM

Great Point Partners's Q3 2013 Portfolio in Review

Q3 2013 is the first quarter with a 13F filing on record for Great Point Partners, which disclosed 32 positions worth $144M. Its ten largest holdings account for 70% of the portfolio.

Its largest position is HYPERION THERAPEUTICS INC COM STK (DE): 820,906 shares worth $21.4M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets.

  • Great Point Partners's largest Q3 2013 buy was HYPERION THERAPEUTICS INC COM STK (DE): 820,906 shares worth $21.4M.
  • Great Point Partners's ten largest holdings make up 70% of its $144M portfolio in Q3 2013.
  • Great Point Partners disclosed 32 positions in Q3 2013, its first 13F filing on record.

Based on Great Point Partners's 13F filing for Q3 2013, filed 14 Nov 2013.